Merck KGaA (MKKGY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - Specialty & Generic Branche. Der Hauptsitz des Unternehmens ist in Darmstadt, Germany. Der aktuelle CEO ist Belen Garijo Lopez.
MKKGY hat IPO-Datum 2007-11-16, 59,020 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $60.04B.
Merck KGaA is a German science and technology company founded in 1668 and headquartered in Darmstadt. Operating through three primary segments—Life Science, Healthcare, and Electronics—the company serves academic, pharmaceutical, biotech, and industrial markets globally. The Life Science segment provides laboratory tools, chemicals, equipment, and process development technologies for drug manufacturers, while also offering testing solutions for environmental and nutritional analysis. The Healthcare segment discovers and manufactures prescription drugs and biopharmaceuticals focused on oncology, neurology, immunology, fertility, endocrinology, and other therapeutic areas, alongside injection devices and monitoring software. The Electronics segment supplies advanced materials for semiconductor and display industries, as well as specialized surface solutions for cosmetics and functional applications. Merck KGaA also pursues strategic partnerships and in-licensing agreements to expand its oncology and specialized therapeutic pipelines.
